AMLX (Amylyx Corp) Forvard P/S multiplikatori
Amylyx Pharmaceuticals (AMLX) o'zining asosiy dorisi bilan bog'liq muvaffaqiyatsizliklardan so'ng, yangi molekulalarni zudlik bilan ishlab chiqib, innovatsiya siklini qaytadan boshlamoqda. Kelajakdagi P/S koeffitsienti bozor kutganlarini aks ettiradi, -2318.10 qiymati esa ushbu metrikaning joriy miqdorini ko'rsatadi. Kompaniyaning daromadlari ALS davolash uchun sug'urta kompaniyalari tomonidan amalga oshirilgan to'lovlarga asoslangan. O'z ishlab chiqarish zavodlarining yo'qligi kompaniyani tashqi kontrakt ishlab chiqaruvchilarga tayanishga majbur qilmoqda.
Amylyx Corp (AMLX) boʻyicha maʼlumotlarning jamlanma tahliliy kesimlari
- bozor narxi va tahlilchilarning maqsadli narxlari:
- biznesning bozor baholash ko'rsatkichlari:
- emitentning balans qiymati statistikasi:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Qarzning xususiy kapitalga nisbati Amylyx Pharmaceuticals|AMLX - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati Amylyx Pharmaceuticals|AMLX - Kompaniyaning jamlangan qarzlari|Balans kapitallashuviga qarzlar Amylyx Corp|AMLX - Kompaniyaning uzoq muddatli majburiyatlari|Kompaniyaning qisqa muddatli qarzlari Amylyx Pharmaceuticals|Tezkor likvidlik ko‘rsatkichi amylyx.com
- moliyaviy natijalar va qiymat multiplikatorlari tafsilotlari:
AMLX - Sof foyda|Kelajakdagi foyda Amylyx Pharmaceuticals|AMLX - Bozor narxining sof foydaga nisbati|Forvard P/E multiplikatori Amylyx|AMLX - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|EV/EBITDA multiplikatori Amylyx Corp|AMLX - Eskirish chegirilmasdan oldingi operatsion foyda|Bir aksiya uchun sof foyda (EPS TTM) Amylyx Pharmaceuticals|AMLX - Bir aksiya uchun sof foyda (EPS TTM)|So'nggi o'n ikki oy davomida bir aksiya uchun foydaning yillik o'sishi amylyx.com|AMLX - Joriy yilda bir aksiya uchun foyda o'sishi|Keyingi yil uchun bir aksiya uchun sof foyda o'sishi prognozi Amylyx Pharmaceuticals
- umumiy tushum va sotuv hajmi ma'lumotlari:
Kompaniyaning fundamental tahlili:Amylyx Pharmaceuticals, Inc. AMLX
Amylyx Pharmaceuticals (AMLX) uchun prognoz qilingan daromad koeffitsienti R&D xodimlarining yo'qotilishi fonida dori vositalarini tijoratlashtirishga bo'lgan bozor ishonchini aks ettiradi. Prognoz qilingan P/S koeffitsienti, choraklik hisobotlarning kechikishlarini hisobga olmagan holda, joriy bozor qiymatini kutilayotgan savdo hajmi bilan bog'laydi. Ushbu ko'rsatkichning pasayishi qimmatga baholanmaganlikni yoki ilmiy salohiyatning zaiflashganligi sababli ortib borayotgan xatarlarni anglatishi mumkin. Investorlar tendentsiya chizig'ini biznesning barqarorligi belgisi sifatida baholashlari lozim.
Amylyx Pharmaceuticals (AMLX) raqobatchilari
Narxning prognoz qilingan daromadga nisbati Biogen BIIB|NBIX (Neurocrine) - Kelajakdagi narxning daromadga nisbati|Regencell - Forvard P/S multiplikatori|Sotuvga nisbatan forvard narx AXSM (Axsome Corp)|ACAD: Forvard P/S multiplikatori|xenon-pharma.com (XENE) - Forvard P/S multiplikatori|Narxning prognoz qilingan daromadga nisbati Viking Therapeutics, Inc.|SUPN: Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati Catalyst Pharmaceuticals Inc (CPRX)|Forvard narx/daromad multiplikatori Denali Corp DNLI|Forvard P/S multiplikatori HRMY (Harmony Biosciences)|Forvard P/S multiplikatori biohavenpharma.com BHVN|Trevi Therapeutics, Inc. - Forvard P/S multiplikatori|Praxis Precision Medicines Inc (PRAX) - Forvard narx/daromad multiplikatori|AVXL: Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati CeriBell EEG (CBLL)|Forvard narx/daromad multiplikatori PRTA|Forvard P/S multiplikatori Alector Therapeutics|Forvard narx/daromad multiplikatori ANNX (Annexon)|Narxning kutilayotgan daromadga nisbati OMER|Forvard P/S multiplikatori NGNE (Neurogene Corp)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati AC Immune Inc (ACIU)|Voyager Therapeutics - Forvard P/S multiplikatori|neumoratx.com (NMRA) - Forvard narx/daromad multiplikatori|SCLX: Forvard P/S multiplikatori|Tevogen Bio Holdings Inc. (TVGN) - Forvard P/S multiplikatori|Narxning prognoz qilingan daromadga nisbati Alpha Cognition Inc|Narxning prognoz qilingan daromadga nisbati CGTX|Narxning prognoz qilingan daromadga nisbati Inhibikase Therapeutics (IKT)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati cassavasciences.com|Forvard P/S multiplikatori ASRT (Assertio)|Forvard P/S multiplikatori Coya Therapeutics Inc COYA|VTGN - Narxning prognoz qilingan daromadga nisbati|Ovid Therapeutics Inc. (OVID) - Forvard narx/daromad multiplikatori|Acumen Pharmaceuticals (ABOS) - Narxning prognoz qilingan daromadga nisbati|CRVO (cervomed.com) - Narxning prognoz qilingan daromadga nisbati|Forvard narx/daromad multiplikatori ATHE|Kapitalizatsiyaning prognoz qilingan daromadga nisbati CLNN (Clene Nanomedicine)|Narxning prognoz qilingan daromadga nisbati PepGen Inc. (PEPG)|Jupiter Neurosciences, Inc. - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|Forvard P/S multiplikatori RLMD (Relmada Therapeutics)|annovisbio.com (ANVS) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|GRCE: Forvard narx/daromad multiplikatori|AIFF - Forvard P/S multiplikatori|anewmeds.com (KLTO) - Narxning prognoz qilingan daromadga nisbati|NeuroSense Therapeutics Ltd. - Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati Reviva Pharmaceuticals|Bozor kapitallashuvining kelajakdagi daromadga nisbati MetaVia, Inc. MTVA|Forvard P/S multiplikatori NRXS|Forvard P/S multiplikatori heliusmedical.com (HSDT)|Narxning prognoz qilingan daromadga nisbati Passage Bio PASG|NEUP - Forvard narx/daromad multiplikatori|NERV: Forvard narx/daromad multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati athira.com|Addex Therapeutics Ltd (ADXN) - Narxning prognoz qilingan daromadga nisbati|ALZN (Alzamend Neuro) - Narxning prognoz qilingan daromadga nisbati|Forvard narx/daromad multiplikatori CYCN|Bozor kapitallashuvining kelajakdagi daromadga nisbati Protagenic PTIX|Forvard narx/daromad multiplikatori KTTA (Pasithea Therapeutics)|cortigent.com - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|Avenue Therapeutics, Inc. - Forvard narx/daromad multiplikatori|Sotuvga nisbatan forvard narx BCLI|CARA - Narxning prognoz qilingan daromadga nisbati|Kelajakdagi narxning daromadga nisbati CHRO|ELYM: Forvard P/S multiplikatori|Intra-Cellular Therapies, Inc. - Sotuvga nisbatan forvard narx|LBPH (Longboard Pharmaceuticals, Inc.) - Forvard P/S multiplikatori|Forvard P/S multiplikatori Marinus Pharmaceuticals Inc|Narxning prognoz qilingan daromadga nisbati NKGen (NKGN)|NRBO (NeuroBo Pharma) - Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati Sage Therapeutics, Inc. SAGE|SNPX - Forvard narx/daromad multiplikatori|Trevena - Forvard P/S multiplikatori|VIGL - Forvard P/S multiplikatori|WENA: Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori Cerevel Corp
